Cross-source evidence timeline
Teriparatide research timeline
Follow 149 selected, directly cited source records from September 22, 1999 through August 13, 2026. This timeline joins source lanes for navigation; it does not infer that one record confirms another.
Source year
2026
Literature metadata
Letter to the Editor: "Comparison of Teriparatide and Denosumab in Patients Switching from Long-Term Bisphosphonate Use".↗
PubMed lists PMID 31408164 in The Journal of clinical endocrinology and metabolism as Comment, Letter, with publication-date metadata of 2019-12-01 (day precision). PeptideScanner associated the retained record with the identity slug teriparatide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.↗
Attributed publication date: December 1, 2019 · day precisionAdded to PeptideScanner August 14, 2026Literature metadata
Targeted drug repurposing in medication-related osteonecrosis of the jaw: a review of teriparatide and pentoxifylline/α-tocopherol protocols.↗
PubMed lists PMID 41852535 in Frontiers in medicine as Journal Article, Review, with publication-date metadata of 2026-03-03 (day precision). PeptideScanner associated the retained record with the identity slug teriparatide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.↗
Attributed publication date: March 3, 2026 · day precisionAdded to PeptideScanner August 14, 2026Literature metadata
Teriparatide in Two Patients With Mucopolysaccharidosis Type IVB.↗
PubMed lists PMID 41987916 in JIMD reports as Journal Article, with publication-date metadata of 2026-04-13 (day precision). PeptideScanner associated the retained record with the identity slug teriparatide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.↗
Attributed publication date: April 13, 2026 · day precisionAdded to PeptideScanner August 14, 2026Literature metadata
Comparing Teriparatide and Bisphosphonates for Postmenopausal Osteoporosis: A Systematic Review and Meta-Analysis of RCTs.↗
PubMed lists PMID 42022682 in Health science reports as Journal Article, Review, with publication-date metadata of 2026-03-13 (day precision). PeptideScanner associated the retained record with the identity slug teriparatide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.↗
Attributed publication date: March 13, 2026 · day precisionAdded to PeptideScanner August 14, 2026Literature metadata
Acute use of teriparatide and palopegteriparatide in the management of hungry bone syndrome following parathyroidectomy.↗
PubMed lists PMID 42058698 in JCEM case reports as Case Reports, Journal Article, with publication-date metadata of 2026-04-28 (day precision). PeptideScanner associated the retained record with the identity slug teriparatide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.↗
Attributed publication date: April 28, 2026 · day precisionAdded to PeptideScanner August 14, 2026Literature metadata
A Comparison Between Bisphosphonates and Teriparatide in the Treatment of Postmenopausal Osteoporosis: A Systematic Review.↗
PubMed lists PMID 42083710 in Cureus as Journal Article, Review, with publication-date metadata of 2026-04-03 (day precision). PeptideScanner associated the retained record with the identity slug teriparatide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.↗
Attributed publication date: April 3, 2026 · day precisionAdded to PeptideScanner August 14, 2026Literature metadata
Transient teriparatide for postoperative hypocalcaemia with hungry bone features.↗
PubMed lists PMID 42592840 in European journal of endocrinology as Journal Article, with publication-date metadata of 2026-08-13 (day precision). PeptideScanner associated the retained record with the identity slug teriparatide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.↗
Attributed publication date: August 13, 2026 · day precisionAdded to PeptideScanner August 13, 2026Literature metadata
PubMed record PMID 42568899↗
PeptideScanner retained PubMed bibliographic metadata for PMID 42568899 at 2026-08-10T10:49:13.608Z. PubMed recorded a metadata revision date of 2026-08-08 and an Entrez history date of 2026-08-08. PeptideScanner associated this retained record with the identity slug teriparatide. These dates describe PubMed metadata history, not the article's original publication date.↗
Added to PeptideScanner August 10, 2026Literature metadata
PubMed record PMID 42570209↗
PeptideScanner retained PubMed bibliographic metadata for PMID 42570209 at 2026-08-10T10:49:13.625Z. PubMed recorded a metadata revision date of 2026-08-08 and an Entrez history date of 2026-08-08. PeptideScanner associated this retained record with the identity slug teriparatide. These dates describe PubMed metadata history, not the article's original publication date.↗
Added to PeptideScanner August 10, 2026Literature metadata
PubMed record PMID 42501079↗
PeptideScanner retained PubMed bibliographic metadata for PMID 42501079 at 2026-08-10T10:49:10.788Z. PubMed recorded a metadata revision date of 2026-08-07 and an Entrez history date of 2026-07-25. PeptideScanner associated this retained record with the identity slug teriparatide. These dates describe PubMed metadata history, not the article's original publication date.↗
Added to PeptideScanner August 10, 2026Literature metadata
PubMed record PMID 41904726↗
PeptideScanner retained PubMed bibliographic metadata for PMID 41904726 at 2026-08-10T10:49:08.825Z. PubMed recorded a metadata revision date of 2026-08-06 and an Entrez history date of 2026-03-29. PeptideScanner associated this retained record with the identity slug teriparatide. These dates describe PubMed metadata history, not the article's original publication date.↗
Added to PeptideScanner August 11, 2026Literature metadata
PubMed record PMID 41949681↗
PeptideScanner retained PubMed bibliographic metadata for PMID 41949681 at 2026-08-10T10:49:08.835Z. PubMed recorded a metadata revision date of 2026-08-06 and an Entrez history date of 2026-04-08. PeptideScanner associated this retained record with the identity slug teriparatide. These dates describe PubMed metadata history, not the article's original publication date.↗
Added to PeptideScanner August 10, 2026Literature metadata
PubMed record PMID 41272927↗
PeptideScanner retained PubMed bibliographic metadata for PMID 41272927 at 2026-08-10T10:49:06.999Z. PubMed recorded a metadata revision date of 2026-08-03 and an Entrez history date of 2025-11-22. PeptideScanner associated this retained record with the identity slug teriparatide. These dates describe PubMed metadata history, not the article's original publication date.↗
Added to PeptideScanner August 11, 2026Literature metadata
PubMed record PMID 41748193↗
PeptideScanner retained PubMed bibliographic metadata for PMID 41748193 at 2026-08-10T10:49:08.774Z. PubMed recorded a metadata revision date of 2026-08-03 and an Entrez history date of 2026-02-26. PeptideScanner associated this retained record with the identity slug teriparatide. These dates describe PubMed metadata history, not the article's original publication date.↗
Added to PeptideScanner August 11, 2026Literature metadata
PubMed record PMID 42532234↗
PeptideScanner retained PubMed bibliographic metadata for PMID 42532234 at 2026-08-10T10:49:12.924Z. PubMed recorded a metadata revision date of 2026-08-03 and an Entrez history date of 2026-07-30. PeptideScanner associated this retained record with the identity slug teriparatide. These dates describe PubMed metadata history, not the article's original publication date.↗
Added to PeptideScanner August 11, 2026Literature metadata
PubMed record PMID 40978515↗
PeptideScanner retained PubMed bibliographic metadata for PMID 40978515 at 2026-08-10T10:49:06.968Z. PubMed recorded a metadata revision date of 2026-08-02 and an Entrez history date of 2025-09-22. PeptideScanner associated this retained record with the identity slug teriparatide. These dates describe PubMed metadata history, not the article's original publication date.↗
Added to PeptideScanner August 12, 2026Literature metadata
PubMed record PMID 41999058↗
PeptideScanner retained PubMed bibliographic metadata for PMID 41999058 at 2026-08-10T10:49:08.848Z. PubMed recorded a metadata revision date of 2026-07-30 and an Entrez history date of 2026-04-18. PeptideScanner associated this retained record with the identity slug teriparatide. These dates describe PubMed metadata history, not the article's original publication date.↗
Added to PeptideScanner August 12, 2026Literature metadata
PubMed record PMID 42513596↗
PeptideScanner retained PubMed bibliographic metadata for PMID 42513596 at 2026-08-10T10:49:12.877Z. PubMed recorded a metadata revision date of 2026-07-30 and an Entrez history date of 2026-07-28. PeptideScanner associated this retained record with the identity slug teriparatide. These dates describe PubMed metadata history, not the article's original publication date.↗
Added to PeptideScanner August 12, 2026Regulatory
Federal Register notice 2026-15285↗
The Federal Register published notice 2026-15285, attributed to FDA and its parent HHS department, on 2026-07-29. Its official title is “Product-Specific Guidances; Revised Draft Guidances for Industry; Availability,” and PeptideScanner's exact reviewed identity mapping connects the document to Glucagon, Liraglutide, Semaglutide, Teriparatide, Tirzepatide and Vosoritide.↗
Added to PeptideScanner August 21, 2026Literature metadata
PubMed record PMID 42398904↗
PeptideScanner retained PubMed bibliographic metadata for PMID 42398904 at 2026-08-10T18:13:53.834Z. PubMed recorded a metadata revision date of 2026-07-29 and an Entrez history date of 2026-07-03. PeptideScanner associated this retained record with the identity slug teriparatide. These dates describe PubMed metadata history, not the article's original publication date.↗
Added to PeptideScanner August 12, 2026Literature metadata
PubMed record PMID 42516799↗
PeptideScanner retained PubMed bibliographic metadata for PMID 42516799 at 2026-08-10T18:13:56.766Z. PubMed recorded a metadata revision date of 2026-07-29 and an Entrez history date of 2026-07-28. PeptideScanner associated this retained record with the identity slug teriparatide. These dates describe PubMed metadata history, not the article's original publication date.↗
Added to PeptideScanner August 12, 2026Literature metadata
PubMed record PMID 42521191↗
PeptideScanner retained PubMed bibliographic metadata for PMID 42521191 at 2026-08-10T18:13:56.780Z. PubMed recorded a metadata revision date of 2026-07-28 and an Entrez history date of 2026-07-28. PeptideScanner associated this retained record with the identity slug teriparatide. These dates describe PubMed metadata history, not the article's original publication date.↗
Added to PeptideScanner August 12, 2026Literature metadata
PubMed record PMID 41686215↗
PeptideScanner retained PubMed bibliographic metadata for PMID 41686215 at 2026-08-10T18:13:40.663Z. PubMed recorded a metadata revision date of 2026-07-26 and an Entrez history date of 2026-02-13. PeptideScanner associated this retained record with the identity slug teriparatide. These dates describe PubMed metadata history, not the article's original publication date.↗
Added to PeptideScanner August 12, 2026Literature metadata
PubMed record PMID 42294947↗
PeptideScanner retained PubMed bibliographic metadata for PMID 42294947 at 2026-08-10T18:13:52.269Z. PubMed recorded a metadata revision date of 2026-07-26 and an Entrez history date of 2026-06-15. PeptideScanner associated this retained record with the identity slug teriparatide. These dates describe PubMed metadata history, not the article's original publication date.↗
Added to PeptideScanner August 12, 2026Literature metadata
PubMed record PMID 42355862↗
PeptideScanner retained PubMed bibliographic metadata for PMID 42355862 at 2026-08-10T18:13:53.757Z. PubMed recorded a metadata revision date of 2026-07-26 and an Entrez history date of 2026-06-26. PeptideScanner associated this retained record with the identity slug teriparatide. These dates describe PubMed metadata history, not the article's original publication date.↗
Added to PeptideScanner August 12, 2026Literature metadata
PubMed record PMID 42355866↗
PeptideScanner retained PubMed bibliographic metadata for PMID 42355866 at 2026-08-10T18:13:53.757Z. PubMed recorded a metadata revision date of 2026-07-26 and an Entrez history date of 2026-06-26. PeptideScanner associated this retained record with the identity slug teriparatide. These dates describe PubMed metadata history, not the article's original publication date.↗
Added to PeptideScanner August 12, 2026Clinical trials
ClinicalTrials.gov record NCT06164795↗
PeptideScanner retained ClinicalTrials.gov record NCT06164795 at 2026-08-10T18:10:03.919Z. Its registry update date was 2026-07-22, and PeptideScanner's reviewed identity mapping was teriparatide.↗
Added to PeptideScanner August 13, 2026Literature metadata
Teriparatide Plus Zoledronic Acid for Osteogenesis Imperfecta: A Randomized Clinical Trial.↗
PubMed lists PMID 42133304 in JAMA as Journal Article, Randomized Controlled Trial, Multicenter Study, with publication-date metadata of 2026-07-14 (day precision). PeptideScanner associated the retained record with the identity slug teriparatide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.↗
Attributed publication date: July 14, 2026 · day precisionAdded to PeptideScanner August 13, 2026Literature metadata
Development of 1 month core-shell microspheres combination formulation containing teriparatide for osteoporosis treatment.↗
PubMed lists PMID 41950644 in Biomaterials as Journal Article, with publication-date metadata of 2026-04-05 (day precision). PeptideScanner associated the retained record with the identity slug teriparatide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.↗
Attributed publication date: April 5, 2026 · day precisionAdded to PeptideScanner August 13, 2026Literature metadata
Teriparatide Plus Zoledronic Acid for Osteogenesis Imperfecta: Research Summary.↗
PubMed lists PMID 42133336 in JAMA as Journal Article, with publication-date metadata of 2026-07-14 (day precision). PeptideScanner associated the retained record with the identity slug teriparatide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.↗
Attributed publication date: July 14, 2026 · day precisionAdded to PeptideScanner August 13, 2026Literature metadata
Persistence of romosozumab vs. teriparatide in Japanese older adults aged ≥ 75 years with osteoporosis: a population-based cohort study.↗
PubMed lists PMID 41400755 in Archives of osteoporosis as Journal Article, Comparative Study, with publication-date metadata of 2025-12-16 (day precision). PeptideScanner associated the retained record with the identity slug teriparatide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.↗
Attributed publication date: December 16, 2025 · day precisionAdded to PeptideScanner August 13, 2026Literature metadata
Bioequivalence of Recombinant Human Teriparatide Injection in Healthy Adult Female Subjects in the Fasting State.↗
PubMed lists PMID 38923284 in Clinical pharmacology in drug development as Journal Article, Randomized Controlled Trial, Research Support, Non-U.S. Gov't, with publication-date metadata of 2024-06-24 (day precision). PeptideScanner associated the retained record with the identity slug teriparatide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.↗
Attributed publication date: June 24, 2024 · day precisionAdded to PeptideScanner August 13, 2026Regulatory
Teriparatide DailyMed SPL version 9↗
DailyMed lists Structured Product Labeling version 9 for the reviewed Teriparatide label family with a published date of 2026-06-30. PeptideScanner retained the exact versioned ZIP byte count and SHA-256 receipt without republishing its contents.↗
Added to PeptideScanner August 22, 2026Literature metadata
Bonegraft Using Octacalcium Phosphate Collagen Composite with Teriparatide and Polylactic Acid Cage.↗
PubMed lists PMID 41311271 in Tissue engineering. Part A as Journal Article, Research Support, Non-U.S. Gov't, with publication-date metadata of 2026-02-16 (day precision). PeptideScanner associated the retained record with the identity slug teriparatide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.↗
Attributed publication date: February 16, 2026 · day precisionAdded to PeptideScanner August 13, 2026Literature metadata
Can Intermittent Teriparatide Facilitate Supraphysiological-Rate Distraction Osteogenesis? A Feasibility Study in the Rabbit Tibial Lengthening Model.↗
PubMed lists PMID 40657227 in Indian journal of orthopaedics as Journal Article, with publication-date metadata of 2025-05-27 (day precision). PeptideScanner associated the retained record with the identity slug teriparatide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.↗
Attributed publication date: May 27, 2025 · day precisionAdded to PeptideScanner August 13, 2026Clinical trials
ClinicalTrials.gov record NCT01293292↗
PeptideScanner retained ClinicalTrials.gov record NCT01293292 at 2026-07-30T16:19:36.921Z. Its registry update date was 2026-05-19, and PeptideScanner's reviewed identity mapping was teriparatide.↗
Added to PeptideScanner August 8, 2026Literature metadata
Teriparatide use during an economic crisis: baseline data from the Greek cohort of the Extended Forsteo Observational Study (ExFOS).↗
PubMed lists PMID 26044820 in BMC musculoskeletal disorders as Journal Article, Multicenter Study, Observational Study, Research Support, Non-U.S. Gov't, with publication-date metadata of 2015-06-05 (day precision). PeptideScanner associated the retained record with the identity slug teriparatide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.↗
Attributed publication date: June 5, 2015 · day precisionAdded to PeptideScanner August 16, 2026Clinical trials
ClinicalTrials.gov record NCT05151484↗
PeptideScanner retained ClinicalTrials.gov record NCT05151484 at 2026-07-30T16:19:36.911Z. Its registry update date was 2026-05-14, and PeptideScanner's reviewed identity mapping was teriparatide.↗
Added to PeptideScanner August 9, 2026Clinical trials
ClinicalTrials.gov record NCT03770338↗
PeptideScanner retained ClinicalTrials.gov record NCT03770338 at 2026-07-30T16:19:36.903Z. Its registry update date was 2026-05-14, and PeptideScanner's reviewed identity mapping was teriparatide.↗
Added to PeptideScanner August 8, 2026Clinical trials
ClinicalTrials.gov record NCT01155232↗
PeptideScanner retained ClinicalTrials.gov record NCT01155232 at 2026-07-30T16:19:36.922Z. Its registry update date was 2026-05-11, and PeptideScanner's reviewed identity mapping was teriparatide.↗
Added to PeptideScanner August 9, 2026Clinical trials
ClinicalTrials.gov record NCT06558188↗
PeptideScanner retained ClinicalTrials.gov record NCT06558188 at 2026-07-30T16:20:49.311Z. Its registry update date was 2026-04-17, and PeptideScanner's reviewed identity mapping was teriparatide.↗
Added to PeptideScanner August 9, 2026Clinical trials
ClinicalTrials.gov record NCT06264609↗
PeptideScanner retained ClinicalTrials.gov record NCT06264609 at 2026-07-30T16:20:49.326Z. Its registry update date was 2026-04-01, and PeptideScanner's reviewed identity mapping was teriparatide.↗
Added to PeptideScanner August 9, 2026Clinical trials
ClinicalTrials.gov record NCT05866029↗
PeptideScanner retained ClinicalTrials.gov record NCT05866029 at 2026-07-30T16:25:18.004Z. Its registry update date was 2026-01-12, and PeptideScanner's reviewed identity mapping was teriparatide.↗
Added to PeptideScanner August 9, 2026
Source year
2025
Regulatory
Drugs@FDA application ANDA213641↗
The official Drugs@FDA dataset lists original submission 1 for ANDA 213641 with status AP dated 2025-12-12, and names teriparatide among the application record's active ingredients.↗
Added to PeptideScanner August 14, 2026Regulatory
Federal Register notice 2025-22131↗
The Federal Register published notice 2025-22131, attributed to FDA and its parent HHS department, on 2025-12-05. Its official title is “Product-Specific Guidances; Draft and Revised Draft Guidances for Industry; Availability,” and PeptideScanner's exact reviewed identity mapping connects the document to Glucagon, Liraglutide, Semaglutide, Teriparatide, Tirzepatide and Vosoritide.↗
Added to PeptideScanner August 21, 2026Clinical trials
ClinicalTrials.gov record NCT01225055↗
PeptideScanner retained ClinicalTrials.gov record NCT01225055 at 2026-07-30T18:18:33.512Z. Its registry update date was 2025-12-02, and PeptideScanner's reviewed identity mapping was teriparatide.↗
Added to PeptideScanner August 9, 2026Clinical trials
ClinicalTrials.gov record NCT07242612↗
PeptideScanner retained ClinicalTrials.gov record NCT07242612 at 2026-07-30T18:19:48.219Z. Its registry update date was 2025-11-21, and PeptideScanner's reviewed identity mapping was teriparatide.↗
Added to PeptideScanner August 9, 2026Regulatory
Teriparatide DailyMed SPL version 8↗
DailyMed lists Structured Product Labeling version 8 for the reviewed Teriparatide label family with a published date of 2025-07-16. PeptideScanner retained the exact versioned ZIP byte count and SHA-256 receipt without republishing its contents.↗
Added to PeptideScanner August 22, 2026Regulatory
Teriparatide DailyMed SPL version 7↗
DailyMed lists Structured Product Labeling version 7 for the reviewed Teriparatide label family with a published date of 2025-05-12. PeptideScanner retained the exact versioned ZIP byte count and SHA-256 receipt without republishing its contents.↗
Added to PeptideScanner August 22, 2026Clinical trials
ClinicalTrials.gov record NCT03133195↗
PeptideScanner retained ClinicalTrials.gov record NCT03133195 at 2026-07-30T18:32:24.991Z. Its registry update date was 2025-01-15, and PeptideScanner's reviewed identity mapping was teriparatide.↗
Added to PeptideScanner August 9, 2026
Source year
2024
Regulatory
Teriparatide DailyMed SPL version 6↗
DailyMed lists Structured Product Labeling version 6 for the reviewed Teriparatide label family with a published date of 2024-12-30. PeptideScanner retained the exact versioned ZIP byte count and SHA-256 receipt without republishing its contents.↗
Added to PeptideScanner August 22, 2026Regulatory
Federal Register notice 2024-18997↗
The Federal Register published notice 2024-18997, attributed to FDA and its parent HHS department, on 2024-08-23. Its official title is “Product-Specific Guidances; Draft and Revised Draft Guidances for Industry; Availability,” and PeptideScanner's exact reviewed identity mapping connects the document to Teriparatide.↗
Added to PeptideScanner August 21, 2026Regulatory
Teriparatide DailyMed SPL version 5↗
DailyMed lists Structured Product Labeling version 5 for the reviewed Teriparatide label family with a published date of 2024-07-04. PeptideScanner retained the exact versioned ZIP byte count and SHA-256 receipt without republishing its contents.↗
Added to PeptideScanner August 22, 2026Regulatory
Drugs@FDA application NDA218771↗
The official Drugs@FDA dataset lists original submission 1 for NDA 218771 with status AP dated 2024-06-04, and names teriparatide among the application record's active ingredients.↗
Added to PeptideScanner August 14, 2026Clinical trials
ClinicalTrials.gov record NCT04522622↗
PeptideScanner retained ClinicalTrials.gov record NCT04522622 at 2026-07-30T18:46:20.407Z. Its registry update date was 2024-04-23, and PeptideScanner's reviewed identity mapping was teriparatide.↗
Added to PeptideScanner August 9, 2026Clinical trials
ClinicalTrials.gov record NCT06303284↗
PeptideScanner retained ClinicalTrials.gov record NCT06303284 at 2026-07-30T18:47:17.466Z. Its registry update date was 2024-03-18, and PeptideScanner's reviewed identity mapping was teriparatide.↗
Added to PeptideScanner August 9, 2026Regulatory
Teriparatide DailyMed SPL version 4↗
DailyMed lists Structured Product Labeling version 4 for the reviewed Teriparatide label family with a published date of 2024-01-31. PeptideScanner retained the exact versioned ZIP byte count and SHA-256 receipt without republishing its contents.↗
Added to PeptideScanner August 22, 2026
Source year
2023
Regulatory
Teriparatide DailyMed SPL version 3↗
DailyMed lists Structured Product Labeling version 3 for the reviewed Teriparatide label family with a published date of 2023-12-13. PeptideScanner retained the exact versioned ZIP byte count and SHA-256 receipt without republishing its contents.↗
Added to PeptideScanner August 22, 2026Regulatory
Teriparatide DailyMed SPL version 2↗
DailyMed lists Structured Product Labeling version 2 for the reviewed Teriparatide label family with a published date of 2023-11-20. PeptideScanner retained the exact versioned ZIP byte count and SHA-256 receipt without republishing its contents.↗
Added to PeptideScanner August 22, 2026Regulatory
Drugs@FDA application ANDA208569↗
The official Drugs@FDA dataset lists original submission 1 for ANDA 208569 with status AP dated 2023-11-16, and names teriparatide among the application record's active ingredients.↗
Added to PeptideScanner August 14, 2026Regulatory
Drugs@FDA application ANDA211097↗
The official Drugs@FDA dataset lists original submission 1 for ANDA 211097 with status AP dated 2023-11-16, and names teriparatide among the application record's active ingredients.↗
Added to PeptideScanner August 14, 2026Clinical trials
ClinicalTrials.gov record NCT04026256↗
PeptideScanner retained ClinicalTrials.gov record NCT04026256 at 2026-07-30T19:09:38.366Z. Its registry update date was 2023-08-02, and PeptideScanner's reviewed identity mapping was teriparatide.↗
Added to PeptideScanner August 14, 2026Clinical trials
ClinicalTrials.gov record NCT04879420↗
PeptideScanner retained ClinicalTrials.gov record NCT04879420 at 2026-07-30T19:10:42.715Z. Its registry update date was 2023-07-27, and PeptideScanner's reviewed identity mapping was teriparatide.↗
Added to PeptideScanner August 9, 2026Clinical trials
ClinicalTrials.gov record NCT03072147↗
PeptideScanner retained ClinicalTrials.gov record NCT03072147 at 2026-07-30T19:13:03.748Z. Its registry update date was 2023-05-12, and PeptideScanner's reviewed identity mapping was teriparatide.↗
Added to PeptideScanner August 9, 2026Clinical trials
ClinicalTrials.gov record NCT02025179↗
PeptideScanner retained ClinicalTrials.gov record NCT02025179 at 2026-07-30T19:13:03.751Z. Its registry update date was 2023-05-10, and PeptideScanner's reviewed identity mapping was teriparatide.↗
Added to PeptideScanner September 9, 2026Clinical trials
ClinicalTrials.gov record NCT04589819↗
PeptideScanner retained ClinicalTrials.gov record NCT04589819 at 2026-07-30T19:16:22.171Z. Its registry update date was 2023-02-13, and PeptideScanner's reviewed identity mapping was teriparatide.↗
Added to PeptideScanner August 9, 2026Clinical trials
ClinicalTrials.gov record NCT03472846↗
PeptideScanner retained ClinicalTrials.gov record NCT03472846 at 2026-07-30T19:17:35.707Z. Its registry update date was 2023-01-26, and PeptideScanner's reviewed identity mapping was teriparatide.↗
Added to PeptideScanner August 9, 2026Clinical trials
ClinicalTrials.gov record NCT02440581↗
PeptideScanner retained ClinicalTrials.gov record NCT02440581 at 2026-07-30T19:17:35.692Z. Its registry update date was 2023-01-05, and PeptideScanner's reviewed identity mapping was teriparatide.↗
Added to PeptideScanner August 9, 2026
Source year
2022
Clinical trials
ClinicalTrials.gov record NCT01796301↗
PeptideScanner retained ClinicalTrials.gov record NCT01796301 at 2026-07-30T19:32:59.853Z. Its registry update date was 2022-11-29, and PeptideScanner's reviewed identity mapping was teriparatide.↗
Added to PeptideScanner August 9, 2026Clinical trials
ClinicalTrials.gov record NCT04750460↗
PeptideScanner retained ClinicalTrials.gov record NCT04750460 at 2026-07-30T19:32:59.860Z. Its registry update date was 2022-11-10, and PeptideScanner's reviewed identity mapping was teriparatide.↗
Added to PeptideScanner September 9, 2026Clinical trials
ClinicalTrials.gov record NCT00754442↗
PeptideScanner retained ClinicalTrials.gov record NCT00754442 at 2026-07-30T19:40:58.915Z. Its registry update date was 2022-04-01, and PeptideScanner's reviewed identity mapping was teriparatide.↗
Added to PeptideScanner August 9, 2026
Source year
2021
Clinical trials
ClinicalTrials.gov record NCT02023411↗
PeptideScanner retained ClinicalTrials.gov record NCT02023411 at 2026-07-30T20:02:09.392Z. Its registry update date was 2021-06-30, and PeptideScanner's reviewed identity mapping was teriparatide.↗
Added to PeptideScanner August 9, 2026Clinical trials
ClinicalTrials.gov record NCT01292252↗
PeptideScanner retained ClinicalTrials.gov record NCT01292252 at 2026-07-30T20:03:05.485Z. Its registry update date was 2021-05-03, and PeptideScanner's reviewed identity mapping was teriparatide.↗
Added to PeptideScanner August 9, 2026Clinical trials
ClinicalTrials.gov record NCT02176382↗
PeptideScanner retained ClinicalTrials.gov record NCT02176382 at 2026-07-30T20:06:10.499Z. Its registry update date was 2021-02-09, and PeptideScanner's reviewed identity mapping was teriparatide.↗
Added to PeptideScanner August 9, 2026Clinical trials
ClinicalTrials.gov record NCT04206618↗
PeptideScanner retained ClinicalTrials.gov record NCT04206618 at 2026-07-30T20:07:13.493Z. Its registry update date was 2021-01-12, and PeptideScanner's reviewed identity mapping was teriparatide.↗
Added to PeptideScanner August 9, 2026
Source year
2020
Clinical trials
ClinicalTrials.gov record NCT02563353↗
PeptideScanner retained ClinicalTrials.gov record NCT02563353 at 2026-07-30T20:22:36.942Z. Its registry update date was 2020-09-18, and PeptideScanner's reviewed identity mapping was teriparatide.↗
Added to PeptideScanner August 9, 2026
Source year
2019
Clinical trials
ClinicalTrials.gov record NCT01440803↗
PeptideScanner retained ClinicalTrials.gov record NCT01440803 at 2026-07-30T20:42:14.438Z. Its registry update date was 2019-12-11, and PeptideScanner's reviewed identity mapping was teriparatide.↗
Added to PeptideScanner August 9, 2026Regulatory
Drugs@FDA application NDA211939↗
The official Drugs@FDA dataset lists original submission 1 for NDA 211939 with status AP dated 2019-10-04, and names teriparatide among the application record's active ingredients.↗
Added to PeptideScanner August 14, 2026Clinical trials
ClinicalTrials.gov record NCT01709110↗
PeptideScanner retained ClinicalTrials.gov record NCT01709110 at 2026-07-30T20:45:58.285Z. Its registry update date was 2019-09-23, and PeptideScanner's reviewed identity mapping was teriparatide.↗
Added to PeptideScanner August 9, 2026Clinical trials
ClinicalTrials.gov record NCT02239523↗
PeptideScanner retained ClinicalTrials.gov record NCT02239523 at 2026-07-30T20:53:39.666Z. Its registry update date was 2019-04-05, and PeptideScanner's reviewed identity mapping was teriparatide.↗
Added to PeptideScanner August 9, 2026Clinical trials
ClinicalTrials.gov record NCT02472782↗
PeptideScanner retained ClinicalTrials.gov record NCT02472782 at 2026-07-30T20:57:18.711Z. Its registry update date was 2019-01-10, and PeptideScanner's reviewed identity mapping was teriparatide.↗
Added to PeptideScanner August 9, 2026
Source year
2018
Clinical trials
ClinicalTrials.gov record NCT00926380↗
PeptideScanner retained ClinicalTrials.gov record NCT00926380 at 2026-07-30T21:11:31.043Z. Its registry update date was 2018-06-29, and PeptideScanner's reviewed identity mapping was teriparatide.↗
Added to PeptideScanner August 9, 2026
Source year
2017
Clinical trials
ClinicalTrials.gov record NCT01705587↗
PeptideScanner retained ClinicalTrials.gov record NCT01705587 at 2026-07-30T21:22:00.252Z. Its registry update date was 2017-12-12, and PeptideScanner's reviewed identity mapping was teriparatide.↗
Added to PeptideScanner August 9, 2026Regulatory
Federal Register notice 2017-21202↗
The Federal Register published notice 2017-21202, attributed to FDA and its parent HHS department, on 2017-10-03. Its official title is “Abbreviated New Drug Applications for Certain Highly Purified Synthetic Peptide Drug Products That Refer to Listed Drugs of Recombinant Deoxyribonucleic Acid Origin; Draft Guidance for Industry; Availability,” and PeptideScanner's exact reviewed identity mapping connects the document to Glucagon, Liraglutide and Teriparatide.↗
Added to PeptideScanner August 21, 2026Clinical trials
ClinicalTrials.gov record NCT01153425↗
PeptideScanner retained ClinicalTrials.gov record NCT01153425 at 2026-07-30T21:23:14.757Z. Its registry update date was 2017-08-04, and PeptideScanner's reviewed identity mapping was teriparatide.↗
Added to PeptideScanner August 9, 2026Clinical trials
ClinicalTrials.gov record NCT00759772↗
PeptideScanner retained ClinicalTrials.gov record NCT00759772 at 2026-07-30T21:24:24.229Z. Its registry update date was 2017-05-11, and PeptideScanner's reviewed identity mapping was teriparatide.↗
Added to PeptideScanner August 9, 2026Clinical trials
ClinicalTrials.gov record NCT01400516↗
PeptideScanner retained ClinicalTrials.gov record NCT01400516 at 2026-07-30T21:24:24.225Z. Its registry update date was 2017-04-11, and PeptideScanner's reviewed identity mapping was teriparatide.↗
Added to PeptideScanner August 9, 2026
Source year
2016
Clinical trials
ClinicalTrials.gov record NCT01309399↗
PeptideScanner retained ClinicalTrials.gov record NCT01309399 at 2026-07-30T21:34:56.507Z. Its registry update date was 2016-11-23, and PeptideScanner's reviewed identity mapping was teriparatide.↗
Added to PeptideScanner August 9, 2026Clinical trials
ClinicalTrials.gov record NCT02478879↗
PeptideScanner retained ClinicalTrials.gov record NCT02478879 at 2026-07-30T21:36:16.907Z. Its registry update date was 2016-08-23, and PeptideScanner's reviewed identity mapping was teriparatide.↗
Added to PeptideScanner August 9, 2026
Source year
2015
Clinical trials
ClinicalTrials.gov record NCT01753856↗
PeptideScanner retained ClinicalTrials.gov record NCT01753856 at 2026-07-30T21:39:57.682Z. Its registry update date was 2015-10-08, and PeptideScanner's reviewed identity mapping was teriparatide.↗
Added to PeptideScanner August 9, 2026Clinical trials
ClinicalTrials.gov record NCT01360424↗
PeptideScanner retained ClinicalTrials.gov record NCT01360424 at 2026-07-30T21:41:27.767Z. Its registry update date was 2015-09-29, and PeptideScanner's reviewed identity mapping was teriparatide.↗
Added to PeptideScanner August 9, 2026Clinical trials
ClinicalTrials.gov record NCT00005006↗
PeptideScanner retained ClinicalTrials.gov record NCT00005006 at 2026-07-30T21:41:27.764Z. Its registry update date was 2015-08-19, and PeptideScanner's reviewed identity mapping was teriparatide.↗
Added to PeptideScanner August 9, 2026Clinical trials
ClinicalTrials.gov record NCT00473265↗
PeptideScanner retained ClinicalTrials.gov record NCT00473265 at 2026-07-30T21:41:27.762Z. Its registry update date was 2015-07-16, and PeptideScanner's reviewed identity mapping was teriparatide.↗
Added to PeptideScanner August 9, 2026Clinical trials
ClinicalTrials.gov record NCT01473589↗
PeptideScanner retained ClinicalTrials.gov record NCT01473589 at 2026-07-30T21:42:40.788Z. Its registry update date was 2015-04-16, and PeptideScanner's reviewed identity mapping was teriparatide.↗
Added to PeptideScanner August 9, 2026Clinical trials
ClinicalTrials.gov record NCT01473602↗
PeptideScanner retained ClinicalTrials.gov record NCT01473602 at 2026-07-30T21:42:40.804Z. Its registry update date was 2015-04-16, and PeptideScanner's reviewed identity mapping was teriparatide.↗
Added to PeptideScanner August 9, 2026Clinical trials
ClinicalTrials.gov record NCT02416271↗
PeptideScanner retained ClinicalTrials.gov record NCT02416271 at 2026-07-30T21:42:40.803Z. Its registry update date was 2015-04-14, and PeptideScanner's reviewed identity mapping was teriparatide.↗
Added to PeptideScanner August 9, 2026
Source year
2014
Clinical trials
ClinicalTrials.gov record NCT01166958↗
PeptideScanner retained ClinicalTrials.gov record NCT01166958 at 2026-07-30T21:54:46.558Z. Its registry update date was 2014-09-22, and PeptideScanner's reviewed identity mapping was teriparatide.↗
Added to PeptideScanner August 9, 2026Clinical trials
ClinicalTrials.gov record NCT01611571↗
PeptideScanner retained ClinicalTrials.gov record NCT01611571 at 2026-07-30T21:54:46.552Z. Its registry update date was 2014-03-04, and PeptideScanner's reviewed identity mapping was teriparatide.↗
Added to PeptideScanner August 9, 2026
Source year
2013
Clinical trials
ClinicalTrials.gov record NCT00000400↗
PeptideScanner retained ClinicalTrials.gov record NCT00000400 at 2026-07-30T21:55:56.630Z. Its registry update date was 2013-12-09, and PeptideScanner's reviewed identity mapping was teriparatide.↗
Added to PeptideScanner August 13, 2026Literature metadata
Early callus formation in human hip fracture treated with internal fixation and teriparatide.↗
PubMed lists PMID 18843769 in The Journal of rheumatology as Case Reports, Letter, with publication-date metadata of 2008-10 (month precision). PeptideScanner associated the retained record with the identity slug teriparatide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.↗
Attributed publication date: October 2008 · month precisionAdded to PeptideScanner September 9, 2026Literature metadata
Actual versus predicted first-year utilization patterns of teriparatide in patients with employer-sponsored health insurance.↗
PubMed lists PMID 18021497 in Current medical research and opinion as Journal Article, Research Support, Non-U.S. Gov't, with publication-date metadata of 2007-12 (month precision). PeptideScanner associated the retained record with the identity slug teriparatide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.↗
Attributed publication date: December 2007 · month precisionAdded to PeptideScanner August 14, 2026Literature metadata
Teriparatide and orthopedic surgery.↗
PubMed lists PMID 18182888 in Aging clinical and experimental research as Journal Article, with publication-date metadata of 2007-08 (month precision). PeptideScanner associated the retained record with the identity slug teriparatide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.↗
Attributed publication date: August 2007 · month precisionAdded to PeptideScanner August 14, 2026Literature metadata
Teriparatide (forteo) for osteoporsis.↗
PubMed lists PMID 12571538 in The Medical letter on drugs and therapeutics as Clinical Trial, Journal Article, Randomized Controlled Trial, with publication-date metadata of 2003-02-03 (day precision). PeptideScanner associated the retained record with the identity slug teriparatide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.↗
Attributed publication date: February 3, 2003 · day precisionAdded to PeptideScanner August 13, 2026Literature metadata
Treating osteoporosis with teriparatide: many unknowns?↗
PubMed lists PMID 14610756 in Issues in emerging health technologies as Comparative Study, Journal Article, with publication-date metadata of 2003-11 (month precision). PeptideScanner associated the retained record with the identity slug teriparatide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.↗
Attributed publication date: November 2003 · month precisionAdded to PeptideScanner August 13, 2026Literature metadata
Teriparatide (rhPTH 1-34) for the treatment of osteoporosis.↗
PubMed lists PMID 14627183 in International journal of clinical practice as Journal Article, Review, with publication-date metadata of 2003-10 (month precision). PeptideScanner associated the retained record with the identity slug teriparatide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.↗
Attributed publication date: October 2003 · month precisionAdded to PeptideScanner August 13, 2026Literature metadata
[Therapy of osteoporosis: bisphosphonates, SERM's, teriparatide and strontium].↗
PubMed lists PMID 14685711 in Zeitschrift fur Rheumatologie as Comparative Study, English Abstract, Journal Article, Review, with publication-date metadata of 2003-12 (month precision). PeptideScanner associated the retained record with the identity slug teriparatide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.↗
Attributed publication date: December 2003 · month precisionAdded to PeptideScanner August 13, 2026Literature metadata
Teriparatide for severe osteoporosis.↗
PubMed lists PMID 14742769 in The Annals of pharmacotherapy as Journal Article, Review, with publication-date metadata of 2003-12-30 (day precision). PeptideScanner associated the retained record with the identity slug teriparatide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.↗
Attributed publication date: December 30, 2003 · day precisionAdded to PeptideScanner August 13, 2026Literature metadata
Teriparatide (Forteo) for osteoporosis.↗
PubMed lists PMID 15117021 in American family physician as Journal Article, with publication-date metadata of 2004-04-15 (day precision). PeptideScanner associated the retained record with the identity slug teriparatide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.↗
Attributed publication date: April 15, 2004 · day precisionAdded to PeptideScanner August 13, 2026Literature metadata
Teriparatide (biosynthetic human parathyroid hormone 1-34): a new paradigm in the treatment of osteoporosis.↗
PubMed lists PMID 15228497 in Basic & clinical pharmacology & toxicology as Journal Article, Research Support, Non-U.S. Gov't, Review, with publication-date metadata of 2004-06 (month precision). PeptideScanner associated the retained record with the identity slug teriparatide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.↗
Attributed publication date: June 2004 · month precisionAdded to PeptideScanner August 13, 2026Literature metadata
[Teriparatide (human recombinant 1-34 parathyroid hormone)--a new treatment regimen for severe osteoporosis].↗
PubMed lists PMID 15347166 in Ugeskrift for laeger as Journal Article, Review, with publication-date metadata of 2004-08-02 (day precision). PeptideScanner associated the retained record with the identity slug teriparatide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.↗
Attributed publication date: August 2, 2004 · day precisionAdded to PeptideScanner August 13, 2026Literature metadata
Teriparatide for postmenopausal osteoporosis.↗
PubMed lists PMID 15587764 in Drug and therapeutics bulletin as Journal Article, Review, with publication-date metadata of 2004-12 (month precision). PeptideScanner associated the retained record with the identity slug teriparatide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.↗
Attributed publication date: December 2004 · month precisionAdded to PeptideScanner August 13, 2026Literature metadata
Teriparatide: new preparation. Osteoporosis: less well evaluated than alendronic acid.↗
PubMed lists PMID 15747448 in Prescrire international as Comparative Study, Journal Article, with publication-date metadata of 2005-02 (month precision). PeptideScanner associated the retained record with the identity slug teriparatide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.↗
Attributed publication date: February 2005 · month precisionAdded to PeptideScanner August 13, 2026Literature metadata
Initial experience with teriparatide in the United States.↗
PubMed lists PMID 16684431 in Current medical research and opinion as Journal Article, Research Support, Non-U.S. Gov't, with publication-date metadata of 2006-04 (month precision). PeptideScanner associated the retained record with the identity slug teriparatide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.↗
Attributed publication date: April 2006 · month precisionAdded to PeptideScanner August 13, 2026Literature metadata
PubMed record PMID 24076523↗
PeptideScanner retained PubMed bibliographic metadata for PMID 24076523 at 2026-07-30T21:57:02.024Z. PubMed recorded a metadata revision date of 2013-10-04 and an Entrez history date of 2013-10-01. PeptideScanner associated this retained record with the identity slug teriparatide. These dates describe PubMed metadata history, not the article's original publication date.↗
Added to PeptideScanner August 12, 2026Literature metadata
PubMed record PMID 24026625↗
PeptideScanner retained PubMed bibliographic metadata for PMID 24026625 at 2026-07-30T21:57:02.022Z. PubMed recorded a metadata revision date of 2013-09-26 and an Entrez history date of 2013-09-13. PeptideScanner associated this retained record with the identity slug teriparatide. These dates describe PubMed metadata history, not the article's original publication date.↗
Added to PeptideScanner August 12, 2026Literature metadata
PubMed record PMID 23982227↗
PeptideScanner retained PubMed bibliographic metadata for PMID 23982227 at 2026-07-30T21:57:02.020Z. PubMed recorded a metadata revision date of 2013-09-16 and an Entrez history date of 2013-08-29. PeptideScanner associated this retained record with the identity slug teriparatide. These dates describe PubMed metadata history, not the article's original publication date.↗
Added to PeptideScanner August 12, 2026Literature metadata
PubMed record PMID 23897194↗
PeptideScanner retained PubMed bibliographic metadata for PMID 23897194 at 2026-07-30T21:57:02.018Z. PubMed recorded a metadata revision date of 2013-07-30 and an Entrez history date of 2013-07-31. PeptideScanner associated this retained record with the identity slug teriparatide. These dates describe PubMed metadata history, not the article's original publication date.↗
Added to PeptideScanner August 12, 2026Clinical trials
ClinicalTrials.gov record NCT00826228↗
PeptideScanner retained ClinicalTrials.gov record NCT00826228 at 2026-07-30T21:55:56.618Z. Its registry update date was 2013-07-11, and PeptideScanner's reviewed identity mapping was teriparatide.↗
Added to PeptideScanner August 9, 2026Clinical trials
ClinicalTrials.gov record NCT01063504↗
PeptideScanner retained ClinicalTrials.gov record NCT01063504 at 2026-07-30T21:55:56.620Z. Its registry update date was 2013-06-19, and PeptideScanner's reviewed identity mapping was teriparatide.↗
Added to PeptideScanner August 9, 2026Clinical trials
ClinicalTrials.gov record NCT00927186↗
PeptideScanner retained ClinicalTrials.gov record NCT00927186 at 2026-07-30T21:55:56.626Z. Its registry update date was 2013-04-04, and PeptideScanner's reviewed identity mapping was teriparatide.↗
Added to PeptideScanner August 9, 2026Literature metadata
PubMed record PMID 22840755↗
PeptideScanner retained PubMed bibliographic metadata for PMID 22840755 at 2026-07-30T21:57:01.388Z. PubMed recorded a metadata revision date of 2013-02-01 and an Entrez history date of 2012-07-31. PeptideScanner associated this retained record with the identity slug teriparatide. These dates describe PubMed metadata history, not the article's original publication date.↗
Added to PeptideScanner August 12, 2026Clinical trials
ClinicalTrials.gov record NCT01430104↗
PeptideScanner retained ClinicalTrials.gov record NCT01430104 at 2026-07-30T21:55:56.620Z. Its registry update date was 2013-01-14, and PeptideScanner's reviewed identity mapping was teriparatide.↗
Added to PeptideScanner August 9, 2026
Source year
2012
Literature metadata
PubMed record PMID 22986396↗
PeptideScanner retained PubMed bibliographic metadata for PMID 22986396 at 2026-07-30T22:15:26.556Z. PubMed recorded a metadata revision date of 2012-09-18 and an Entrez history date of 2012-09-19. PeptideScanner associated this retained record with the identity slug teriparatide. These dates describe PubMed metadata history, not the article's original publication date.↗
Added to PeptideScanner August 12, 2026Clinical trials
ClinicalTrials.gov record NCT01078805↗
PeptideScanner retained ClinicalTrials.gov record NCT01078805 at 2026-07-30T22:14:20.917Z. Its registry update date was 2012-06-26, and PeptideScanner's reviewed identity mapping was teriparatide.↗
Added to PeptideScanner August 9, 2026
Source year
2011
Clinical trials
ClinicalTrials.gov record NCT00557310↗
PeptideScanner retained ClinicalTrials.gov record NCT00557310 at 2026-07-30T22:15:58.883Z. Its registry update date was 2011-11-11, and PeptideScanner's reviewed identity mapping was teriparatide.↗
Added to PeptideScanner August 9, 2026Clinical trials
ClinicalTrials.gov record NCT00761332↗
PeptideScanner retained ClinicalTrials.gov record NCT00761332 at 2026-07-30T22:15:58.887Z. Its registry update date was 2011-06-21, and PeptideScanner's reviewed identity mapping was teriparatide.↗
Added to PeptideScanner August 9, 2026Clinical trials
ClinicalTrials.gov record NCT00343252↗
PeptideScanner retained ClinicalTrials.gov record NCT00343252 at 2026-07-30T22:15:58.895Z. Its registry update date was 2011-05-26, and PeptideScanner's reviewed identity mapping was teriparatide.↗
Added to PeptideScanner August 9, 2026Clinical trials
ClinicalTrials.gov record NCT00696644↗
PeptideScanner retained ClinicalTrials.gov record NCT00696644 at 2026-07-30T22:15:58.886Z. Its registry update date was 2011-05-09, and PeptideScanner's reviewed identity mapping was teriparatide.↗
Added to PeptideScanner August 9, 2026Clinical trials
ClinicalTrials.gov record NCT00439244↗
PeptideScanner retained ClinicalTrials.gov record NCT00439244 at 2026-07-30T22:15:58.884Z. Its registry update date was 2011-04-20, and PeptideScanner's reviewed identity mapping was teriparatide.↗
Added to PeptideScanner August 9, 2026
Source year
2010
Clinical trials
ClinicalTrials.gov record NCT00259298↗
PeptideScanner retained ClinicalTrials.gov record NCT00259298 at 2026-07-30T22:25:23.113Z. Its registry update date was 2010-08-11, and PeptideScanner's reviewed identity mapping was teriparatide.↗
Added to PeptideScanner August 9, 2026
Source year
2009
Clinical trials
ClinicalTrials.gov record NCT00414973↗
PeptideScanner retained ClinicalTrials.gov record NCT00414973 at 2026-07-30T22:26:45.016Z. Its registry update date was 2009-10-28, and PeptideScanner's reviewed identity mapping was teriparatide.↗
Added to PeptideScanner August 9, 2026Clinical trials
ClinicalTrials.gov record NCT00051558↗
PeptideScanner retained ClinicalTrials.gov record NCT00051558 at 2026-07-30T22:26:45.005Z. Its registry update date was 2009-03-12, and PeptideScanner's reviewed identity mapping was teriparatide.↗
Added to PeptideScanner August 9, 2026
Source year
2008
Literature metadata
PubMed record PMID 18623910↗
PeptideScanner retained PubMed bibliographic metadata for PMID 18623910 at 2026-07-30T22:38:13.927Z. PubMed recorded a metadata revision date of 2008-07-14 and an Entrez history date of 2008-07-16. PeptideScanner associated this retained record with the identity slug teriparatide. These dates describe PubMed metadata history, not the article's original publication date.↗
Added to PeptideScanner August 12, 2026Literature metadata
PubMed record PMID 18477986↗
PeptideScanner retained PubMed bibliographic metadata for PMID 18477986 at 2026-07-30T22:38:13.910Z. PubMed recorded a metadata revision date of 2008-06-23 and an Entrez history date of 2008-05-15. PeptideScanner associated this retained record with the identity slug teriparatide. These dates describe PubMed metadata history, not the article's original publication date.↗
Added to PeptideScanner August 11, 2026Clinical trials
ClinicalTrials.gov record NCT00670501↗
PeptideScanner retained ClinicalTrials.gov record NCT00670501 at 2026-07-30T22:36:49.601Z. Its registry update date was 2008-05-01, and PeptideScanner's reviewed identity mapping was teriparatide.↗
Added to PeptideScanner August 9, 2026Literature metadata
PubMed record PMID 18334980↗
PeptideScanner retained PubMed bibliographic metadata for PMID 18334980 at 2026-07-30T22:38:13.898Z. PubMed recorded a metadata revision date of 2008-04-28 and an Entrez history date of 2008-03-13. PeptideScanner associated this retained record with the identity slug teriparatide. These dates describe PubMed metadata history, not the article's original publication date.↗
Added to PeptideScanner August 11, 2026
Source year
2007
Clinical trials
ClinicalTrials.gov record NCT00191867↗
PeptideScanner retained ClinicalTrials.gov record NCT00191867 at 2026-07-30T22:39:13.109Z. Its registry update date was 2007-11-06, and PeptideScanner's reviewed identity mapping was teriparatide.↗
Added to PeptideScanner August 9, 2026Clinical trials
ClinicalTrials.gov record NCT00190944↗
PeptideScanner retained ClinicalTrials.gov record NCT00190944 at 2026-07-30T22:39:13.107Z. Its registry update date was 2007-10-12, and PeptideScanner's reviewed identity mapping was teriparatide.↗
Added to PeptideScanner August 9, 2026Clinical trials
ClinicalTrials.gov record NCT00532207↗
PeptideScanner retained ClinicalTrials.gov record NCT00532207 at 2026-07-30T22:39:13.109Z. Its registry update date was 2007-09-20, and PeptideScanner's reviewed identity mapping was teriparatide.↗
Added to PeptideScanner August 9, 2026Clinical trials
ClinicalTrials.gov record NCT00532545↗
PeptideScanner retained ClinicalTrials.gov record NCT00532545 at 2026-07-30T22:39:13.108Z. Its registry update date was 2007-09-20, and PeptideScanner's reviewed identity mapping was teriparatide.↗
Added to PeptideScanner August 9, 2026Clinical trials
ClinicalTrials.gov record NCT00239629↗
PeptideScanner retained ClinicalTrials.gov record NCT00239629 at 2026-07-30T22:39:13.108Z. Its registry update date was 2007-06-12, and PeptideScanner's reviewed identity mapping was teriparatide.↗
Added to PeptideScanner August 9, 2026Clinical trials
ClinicalTrials.gov record NCT00079924↗
PeptideScanner retained ClinicalTrials.gov record NCT00079924 at 2026-07-30T22:39:13.107Z. Its registry update date was 2007-05-25, and PeptideScanner's reviewed identity mapping was teriparatide.↗
Added to PeptideScanner August 13, 2026Clinical trials
ClinicalTrials.gov record NCT00035256↗
PeptideScanner retained ClinicalTrials.gov record NCT00035256 at 2026-07-30T22:39:13.109Z. Its registry update date was 2007-05-15, and PeptideScanner's reviewed identity mapping was teriparatide.↗
Added to PeptideScanner August 13, 2026Clinical trials
ClinicalTrials.gov record NCT00191321↗
PeptideScanner retained ClinicalTrials.gov record NCT00191321 at 2026-07-30T22:39:13.108Z. Its registry update date was 2007-01-26, and PeptideScanner's reviewed identity mapping was teriparatide.↗
Added to PeptideScanner August 13, 2026Clinical trials
ClinicalTrials.gov record NCT00191893↗
PeptideScanner retained ClinicalTrials.gov record NCT00191893 at 2026-07-30T22:39:13.108Z. Its registry update date was 2007-01-26, and PeptideScanner's reviewed identity mapping was teriparatide.↗
Added to PeptideScanner August 13, 2026
Source year
2006
Clinical trials
ClinicalTrials.gov record NCT00046137↗
PeptideScanner retained ClinicalTrials.gov record NCT00046137 at 2026-07-30T22:49:18.183Z. Its registry update date was 2006-07-20, and PeptideScanner's reviewed identity mapping was teriparatide.↗
Added to PeptideScanner August 13, 2026
Source year
2002
Regulatory
Drugs@FDA application NDA021318↗
The official Drugs@FDA dataset lists original submission 1 for NDA 021318 with status AP dated 2002-11-26, and names teriparatide among the application record's active ingredients.↗
Added to PeptideScanner August 14, 2026
Source year
2001
Regulatory
Federal Register notice 01-14410↗
The Federal Register published notice 01-14410, attributed to FDA and its parent HHS department, on 2001-06-08. Its official title is “Endocrinologic and Metabolic Drugs Advisory Committe; Notice of Meeting,” and PeptideScanner's exact reviewed identity mapping connects the document to Pramlintide and Teriparatide.↗
Added to PeptideScanner August 21, 2026
Source year
1999
Regulatory
Federal Register notice 99-24595↗
The Federal Register published notice 99-24595, attributed to FDA and its parent HHS department, on 1999-09-22. Its official title is “Wallace Laboratories et al.; Withdrawal of Approval of 18 New Drug Applications and 44 Abbreviated New Drug Applications,” and PeptideScanner's exact reviewed identity mapping connects the document to Teriparatide.↗
Added to PeptideScanner August 21, 2026